Brain metastasis from hepatocellular carcinoma: the role of surgery as a prognostic factor
Open Access
- 1 December 2013
- journal article
- case report
- Published by Springer Nature in BMC Cancer
- Vol. 13 (1) , 567
Abstract
The incidence of brain metastasis from hepatocellular carcinoma (HCC) is expected to increase as a result of prolonged survival due to the recent advances in HCC treatment. However, there is no definite treatment strategy for brain metastasis from HCC mainly due to its rarity and dismal prognosis. To provide helpful recommendations in treatment of brain metastasis from HCC, the authors aimed to identify prognostic factors that influence survival rates with a review of the recently published data.Keywords
This publication has 15 references indexed in Scilit:
- Brain surgery in patients with liver cirrhosisJournal of Neurosurgery, 2012
- Brain metastases from hepatocellular carcinoma: clinical features and prognostic factorsBMC Cancer, 2012
- Hepatocellular CarcinomaAnnals of Surgery, 2011
- Little Response of Cerebral Metastasis from Hepatocellular Carcinoma to Any TreatmentsJournal of Korean Neurosurgical Society, 2010
- The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guidelineJournal of Neuro-Oncology, 2009
- Prediction, clinical characteristics and prognosis of intracerebral hemorrhage in hepatocellular carcinoma patients with intracerebral metastasisJournal of Clinical Neuroscience, 2009
- Intracranial metastasis of hepatocellular carcinoma: review of 45 casesSurgical Neurology, 2004
- Hepatocellular CarcinomaJournal of Clinical Gastroenterology, 2002
- Minimal criteria for placement of adults on the liver transplant waiting list: A report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver DiseasesLiver Transplantation and Surgery, 1997
- Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trialsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1997